QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
Technology Ventures News
Health advancements made at OMRF could translate to better health for your pets.
Visiting attendees represented some of the top names in in the industry.
The project is focused on lupus, which affects up to 1.5 million Americans.
Sam McNeal, Ph.D., and Michael Sweeney have joined the Technology Ventures staff.
Goal: to deliver new and better treatment options to patients